Gabor Csanyi, PhD.

Gábor Csányi, PhD.

Assistant Professor, Vascular Biology Center

Pharmacology and Toxicology


Contact Info

Phone: (706) 721-1437
Fax: (706) 721-9799
Office: CB-3330
Lab: CB-3201-B, 3208, and 3207B

Education and Training

Post Doctoral Training
University of Pittsburgh
Vascular Medicine Institute.
Department of Pharmacology & Chemical Biology.

University of Szeged, Hungary.
Jagiellonian University,
Krakow, Poland

University of Szeged, Hungary.
Faculty of Pharmacy.

Honors and Awards

2013  Best Poster Presentation, Department of Pharmacology and Chemical Biology, Annual Retreat, Pittsburgh, PA, USA.

2012  New Investigator Travel Award, AHA’s Council for High Blood Pressure, Research, Washington, D.C.

2010 - 2012 Great Rivers Affiliate Postdoctoral Fellowship, AHA (10POST3030009)

2010  Young Investigator Award, Society for Free Radical Biology and Medicine (SFRBM), Orlando, FL, USA

2009  Young Investigator Award, SFRBM, San Francisco, CA, USA

2008  PhD. University of Szeged, Hungary - Summa Cum Laude

2007  Queen Jadwiga Fund, Predoctoral Scholarship, Jagiellonian University, Krakow, Poland

2004 - 2005 Jozef Dietl Scholarship, Jagiellonian University, Krakow, Poland

2003  Eutimia-award, Scientific Research Student Congress, Szeged, Hungary

2003  First Prize, Scientific Research Student Congress, Szeged, Hungary

Other Services

Grant Review

Diabetes UK Foundation


2012 - Present:  Special Issue Editor; Oxidative Stress in Vascular Disease; International Journal of Molecular Sciences.

Editorial Board

2014 - Present - Annals of Vascular Medicine and Research

Journal Reviewer

• Antioxidants & Redox Signaling
• Arteriosclerosis, Thrombosis, and Vascular Biology
• British Journal of Pharmacology
• American Journal of Physiology - Heart and Circulatory Physiology
• International Journal of Molecular Sciences
• Microcirculation

Research and Training Grants Awarded

Ongoing Research Support

5K99HL114648-02  (Csanyi, G.)        08/23/2013 – 07/31/2015
“A Novel Role of Macrophage TSP1-CD47 Signaling in Atherosclerosis”
The goal of this study is to investigate whether activation of CD47 by thrombospondin 1 increases NADPH oxidase-derived reactive oxygen species generation in macrophages leading to initiation and progression of atherosclerosis.
Role:  Principal Investigator

Completed Research Support

AHA Great Rivers Affiliate Postdoctoral Fellowship

“Thrombospondin 1 (TSP1) in Oxidative Stress-Mediated Vascular Dysfunction”
The goal of this study was to test whether thrombospondin-1 via increasing generation of reactive oxygen species in vascular smooth muscle cells regulates vascular tone.

  Information updated as of March 29, 2017